86
Views
15
CrossRef citations to date
0
Altmetric
Original

Utility of peripheral blood dual color, double fusion fluorescent in situ hybridization for BCR/ABL fusion to assess cytogenetic remission status in chronic myeloid leukemia

, , &
Pages 2055-2061 | Received 27 Mar 2006, Accepted 03 May 2006, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

David L DeRemer, Katerina Katsanevas & Celalettin Ustun. (2011) Critical appraisal of nilotinib in frontline treatment of chronic myeloid leukemia. Cancer Management and Research 3, pages 65-78.
Read now
Thoralf Lange & Michael W Deininger. (2010) Molecular diagnostics in chronic myeloid leukemia. Expert Opinion on Medical Diagnostics 4:2, pages 113-124.
Read now

Articles from other publishers (13)

Deepak Kumar Mishra, Indranil Dey, Rakesh Demde, Sushant Vinarkar & Mayur Parihar. (2023) Disease Response Assessment Modalities in Chronic Myeloid Leukemia: Past, Present, and Future. Indian Journal of Medical and Paediatric Oncology 44:06, pages 592-601.
Crossref
Michael W. DeiningerNeil P. ShahJessica K. AltmanEllin BermanRavi BhatiaBhavana BhatnagarDaniel J. DeAngeloJason GotlibGabriela HobbsLori ManessMonica MeadLeland MethenySanjay MohanJoseph O. MooreKiran NaqviVivian OehlerArnel M. PalleraMrinal PatnaikKeith PratzIskra PusicMichal G. RoseB. Douglas SmithDavid S. SnyderKendra L. SweetMoshe TalpazJames ThompsonDavid T. Yang, Kristina M. Gregory & Hema Sundar. (2020) Chronic Myeloid Leukemia, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network 18:10, pages 1385-1415.
Crossref
Ayalew Tefferi, Curtis A. Hanson & Rhett P. Ketterling. (2017) Revisiting the need for bone marrow examination in chronic myeloid leukemia. American Journal of Hematology 93:1, pages 5-7.
Crossref
Barbara J. Bain. 2017. Leukaemia Diagnosis. Leukaemia Diagnosis 371 416 .
P. S. Kadam Amare, H. Jain, S. Kabre, D. Walke, H. Menon, M. Sengar, N. Khatri, B. Bagal, U. Dangi, H. Jain, P. G. Subramanian & S. Gujral. (2016) Characterization of Genomic Events Other than Ph and Evaluation of Prognostic Influence on Imatinib in Chronic Myeloid Leukemia (CML): A Study on 1449 Patients from India. Journal of Cancer Therapy 07:04, pages 285-296.
Crossref
Lotta Ohm, Ingrid Arvidsson, Gisela Barbany, Robert Hast & Leif Stenke. (2012) Early landmark analysis of imatinib treatment in CML chronic phase: Less than 10% BCR‐ABL by FISH at 3 months associated with improved long‐term clinical outcome. American Journal of Hematology 87:8, pages 760-765.
Crossref
Yanming Zhang & Janet D. Rowley. (2011) Chronic Myeloid Leukemia: Current Perspectives. Clinics in Laboratory Medicine 31:4, pages 687-698.
Crossref
Lisa Lima, Leon Bernal‐Mizrachi, Debra Saxe, Karen P. Mann, Mourad Tighiouart, Martha Arellano, Leonard Heffner, Morgan McLemore, Amelia Langston, Elliott Winton & Hanna Jean Khoury. (2010) Peripheral blood monitoring of chronic myeloid leukemia during treatment with imatinib, second‐line agents, and beyond. Cancer 117:6, pages 1245-1252.
Crossref
Christine M. Morris. 2011. Cancer Cytogenetics. Cancer Cytogenetics 33 61 .
David S. Bosler. 2011. Hematopathology. Hematopathology 215 253 .
Barbara J. Bain. 2010. Leukaemia Diagnosis. Leukaemia Diagnosis 261 300 .
Nicoletta TestoniGiulia MarzocchiSimona LuattiMarilina AmabileCarmen BaldazziMonica StacchiniMauro NanniGiovanna Rege-CambrinEmilia GiuglianoUrsula GiussaniElisabetta AbruzzeseSimonetta KerimMaria Grazia GrimoldiAlessandro GozzettiBarbara CrescenziCarlo CarcassiPaolo BernasconiAntonio CuneoFrancesco AlbanoGiuseppina FugazzaAlfonso Zaccaria, Giovanni MartinelliFabrizio Pane, Gianantonio RostiMichele Baccarani. (2009) Chronic myeloid leukemia: a prospective comparison of interphase fluorescence in situ hybridization and chromosome banding analysis for the definition of complete cytogenetic response: a study of the GIMEMA CML WP. Blood 114:24, pages 4939-4943.
Crossref
Ryan A. Knudson, Brandon M. Shearer & Rhett P. Ketterling. (2007) Automated Duet spot counting system and manual technologist scoring using dual-fusion fluorescence in situ hybridization (D-FISH) strategy: comparison and application to FISH minimal residual disease testing in patients with chronic myeloid leukemia. Cancer Genetics and Cytogenetics 175:1, pages 8-18.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.